Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Praluent
Praluent
Why Regeneron’s down on a positive FDA recommendation
CNBC
Wed, 06/10/15 - 02:36 pm
Regeneron
Sanofi
Praluent
FDA
advisory panels
PCSK9 inhibitors
How The New Cholesterol Drugs From Amgen And Regeneron Could Still Be Blockbusters
Forbes
Wed, 06/10/15 - 09:08 am
Amgen
Regeneron
PCSK9 inhibitors
Repatha
Praluent
Sanofi/Regeneron's PCSK9 blockbuster-in-waiting gets prelim FDA nod
BioPharma Dive
Tue, 06/9/15 - 06:33 pm
Sanofi
Regeneron
PCSK9 inhibitors
FDA
advisory panels
Praluent
PCSK9 adcomm preview: what's at stake
Medical Marketing and Media
Tue, 06/9/15 - 09:32 am
PCSK9 inhibitors
FDA
advisory panels
Sanofi
Regeneron
Amgen
Repatha
Praluent
The Fight Against Cholesterol Heats Up; FDA Panel Considers Drugs from Regeneron, Amgen Next Week
Barron's
Fri, 06/5/15 - 12:22 pm
FDA
advisory panels
Regeneron
Sanofi
Amgen
PCSK9 inhibitors
Praluent
5 Drugs That Could Be Summer Blockbusters
Investors.com
Wed, 05/27/15 - 11:06 am
Valeant Pharmaceuticals
Actavis
Xifaxan
Orkambi
Vertex Pharmaceuticals
Regeneron
Sanofi
Amgen
Repatha
eluxadoline
Praluent
The Gilead effect: PCSK9 rivals Amgen, Sanofi/Regeneron prep for a price war
Fierce Biotech
Tue, 05/26/15 - 04:52 pm
Gilead Sciences
PCSK9 inhibitors
Amgen
Sanofi
Regeneron
drug pricing
Repatha
Praluent
Fight over hot new cholesterol drugs may be won in milligrams
Yahoo/Reuters
Tue, 05/26/15 - 09:37 am
Amgen
Repatha
Regeneron
Sanofi
Praluent
Amgen's PCSK9 cholesterol game-changer could beat Sanofi's to an EU approval
BioPharma Dive
Thu, 05/21/15 - 08:47 am
Amgen
PCSK9 inhibitor
Repatha
Europe
Sanofi
Regeneron
Praluent
11 promising drugs poised to be the next billion-dollar blockbusters
Yahoo/Business Insider
Sat, 03/28/15 - 10:26 am
Opdivo
Praluent
LCZ696
lumacaftor
Viekira Pak
evolocumab
Gardasil 9
brexpiprazole
Toujeo
Cosentyx
Bristol-Myers Squibb
Regeneron
Sanofi
Novartis
Pfizer
AbbVie
Amge
Astellas
Merck
Otsuka
Lundbeck
Vertex Pharmaceuticals
Opdivo, Praluent and LCZ-696 top a launch crop poised for $27B in sales
Fierce Pharma Marketing
Wed, 03/25/15 - 03:13 pm
drug launches
Opdivo
Bristol-Myers Squibb
Praluent
Sanofi
Regeneron
LCZ696
Novartis
Why 2015 is the year of the biopharma blockbuster—with charts
BioPharma Dive
Tue, 03/24/15 - 10:29 am
biotech
Opdivo
Praluent
LCZ696
Ibrance
Viekira Pak
evolocumab
Gardasil 9
Bristol-Myers Squibb
Regeneron
Sanofi
Novartis
Pfizer
Vertex Pharmaceuticals
Merck
Amgen
AbbVie
Astellas
Bristol, Sanofi and Novartis drugs to shine among 2015 launches
Yahoo/Reuters
Mon, 03/23/15 - 09:21 am
drug launches
Sanofi
Novartis
Bristol-Myers Squibb. LCZ-696
Opdivo
Praluent
Pages
« first
‹ previous
1
2
3
4
5
6